The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

with unchanged metronidazole accounting for approximately 20% of the total. Discontinue consumption of alcoholic beverages or products containing propylene glycol while taking Flagyl and for at ...

with unchanged metronidazole accounting for approximately 20% of the total. Discontinue consumption of alcoholic beverages or products containing propylene glycol while taking Flagyl and for at ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

In this case, the cause may be in the patient's use of medication prior to labor. Metronidazole (Flagyl) is a common and effective treatment for bacterial vaginosis. A known adverse effect of ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

New Delhi: A particular batch of Metronidazole 400 mg and Paracetamol 500 mg tablets made by Hindustan Antibiotic Limited and Karnataka Antibiotic and Pharmaceuticals Limited, respectively have ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...